Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02115789 · ClinicalTrials.gov registry record
Perceptions of Aesthetic Outcomes of Zigzag and Linear Scars
A clinical trial of Linear Scar and Zigzag Scar, sponsored by University of California, Davis.
- Completed
- Registry status
- 876
- Enrollment target
- 1
- Study location
NCT02115789: Completed study of Linear Scar and Zigzag Scar, sponsored by University of California, Davis.
NCT02115789 is a study of Linear Scar and Zigzag Scar that has completed, run by University of California, Davis. The registered enrollment target is 876 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02115789, a study of Linear Scar and Zigzag Scar, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 876 participants
- Enrollment target
- 1
- Study location
Study Summary
Surgical wounds can be closed in several manners. Some physicians believe that closure in a straight line produces a scar that is more visible and slightly raised when compared to closure in a zigzagging fashion. The researchers of this study believe that there is no difference in the cosmetic appearance of one type of wound closure over the other. To evaluate this, they will provide a survey with visual aids to volunteers to rate the appearance of a straight line scar versus a zigzag scar.
Conditions Studied
Interventions
- BEHAVIORAL Visual Analog Scale
Study Locations (1)
California
- UC Davis, Department of Dermatology - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 876 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-04 |
What the finished NCT02115789 record still lists
NCT02115789 is an observational study that tracks outcomes without assigning an intervention. The registered 876 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Linear Scar appearing as the primary indexed condition, and to 1 intervention - of which Visual Analog Scale is the first listed.
NCT02115789 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02115789 about?
NCT02115789 is a clinical study titled "Perceptions of Aesthetic Outcomes of Zigzag and Linear Scars". Surgical wounds can be closed in several manners. Some physicians believe that closure in a straight line produces a scar that is more visible and slightly raised when compared to closure in a zigzagging fashion. The researchers of this study believe that there is no difference in the cosmetic appea...
What is the current status of trial NCT02115789?
This trial is currently completed. The enrollment target is 876 participants. The study started on 2012-06. Estimated completion is 2014-04.
What conditions does trial NCT02115789 study?
This clinical trial studies the following conditions: Linear Scar, Zigzag Scar.
What interventions are being tested in trial NCT02115789?
The interventions under investigation include: Visual Analog Scale (BEHAVIORAL).
Who is sponsoring clinical trial NCT02115789?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02115789 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- NCT06627647 · 878 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia